The opportunity exists for wholesale investors to express an interest to invest in Plantonin.
Plantonin specialises in the development of scientifically researched high quality nootropics, supplements, and creams for the North American market. Plantonin has internationally protected IP and trademarks allowing scale and sources, where it can, scientifically researched premium New Zealand sustainable ingredients that global consumers trust and that also have a point of difference from others within the market. Following extensive research, Plantonin has developed a range of unique nootropics, supplements, and creams for the North American market. It's unique formulations have been formulated by some of New Zealand’s best biochemists, scientists, naturopaths, and medical herbalists. Currently, Plantonin exports mostly to the North American market selling to 145 million prime customers on the Amazon platform. Sales to date have been promising with strong customer feedback and a pathway to significant growth achievable with the right investment.
The future opportunities are significant with a global market work of $295.5bn being $67bn in the United States alone. The Plantonin executive team have identified other key global markets such as Canada and Asia and work closely with NZTE. Plantonin is seeking capital to scale the business and is offering an opportunity to invest in an exciting global industry, from New Zealand. Plantonin is forecasting to achieve revenues of $9.4M by FTY24 with an EBITDA of $2M just through its current market channels, returning a consistent yield to shareholders.
On offer is the opportunity to invest into Plantonin through ordinary shares priced at $0.78 per share with a minimum investment of $50,000 against a pre-money valuation of $7.8M.
Please review the information memorandum, found in the Documents tab or Register Interest.